CS000000-A | 10/7/22

State of Vaccine Confidence 

Insights Report 

Report 28 | October 10, 2022 

Date Range: May 3 – May 31, 2022

Summary 

Major themes identified from social media, news, and other sources that may impact 

vaccine confidence:

Consumers continue to express their concerns about actual and potential COVID-19 vaccine 

side effects.

Continuing and evolving themes that may impact vaccine confidence: 

 Consumers continue to express their lack of concern about COVID-19 despite rising cases 

and over 1 million dead Americans.

 Parents continue to express concern and hesitation regarding COVID-19 vaccination for 

children. 

Emerging Misinformation Theme Affecting Vaccine Confidence:

 Consumers have questions about the relationship between COVID-19 vaccines and 

monkeypox.

Ways public health and partners can take action. 

 Clarify the benefits of COVID-19 vaccines, including boosters, in preventing severe disease. 

 Work with community members and trusted messengers to create and disseminate messages that explain that some side 

effects are normal and expected. If a vaccinated individual gets COVID-19, vaccination will increase the chances that it is a 

mild case. 

 Develop and amplify messages explaining why vaccines are still important in the COVID-19 prevention response.

 Disseminate messages about community-level risk and corresponding COVID-19 mitigation measures.

 Encourage local health departments, public health experts, and healthcare workers to explain the absence of association 

between COVID-19 vaccines and monkeypox. 

 Utilize proper risk communication strategies when communicating about monkeypox, including tailored communication with 

trusted messengers that explain both what is known and what is not known about the spread and outcomes of monkeypox 

infection.

For findings and ways to act from our other reports, see previousInsights Reports.

Resources: The following link contains social media resources such as graphics, language, and social media calendars that our 

partners can use to address the issues raised in this report: https://centersfordiseasecontrol.sharefile.com/d-s085b6a2566b04a2

3bc3f142f2006199f

SPECIAL UPDATE: CDC partners 

can now report vaccine rumors 

directly to CDC. To report a 

rumor, go to: www.cdc.gov/

report-rumors and start the 

subject line with: "Rumors:" 

and in the question box, give 

as much information about the 

rumor as you can, including a 

description of the rumor, where 

you heard it, and how many 

times you have heard it.

3 Major Theme Impacting Vaccine Confidence,

4 Consumers continue to express their concerns about 

actual and potential COVID-19 vaccine side effects.

5 Continuing and Evolving Themes Impacting Vaccine 

Confidence

5 Concern about COVID-19 despite rising cases and 1 

million dead Americans.

7 Parents continue to express concern and hesitation 

regarding COVID-19 vaccination in children.

9 Emerging Misinformation Theme Affecting Vaccine 

Confidence

9 Consumers have questions about the relationship 

between COVID-19 vaccines and monkeypox.

10 Appendix: Inputs and Sources

The findings and conclusions in this report are those of the author(s) and do not necessarily 

represent the official position of the Centers for Disease Control and Prevention (CDC).

Centers for Disease Control & Prevention, 

COVID-19 Response, Vaccine Task Force

Vaccine Confidence & Demand Team, Insights Unit
Page: 2

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Aims and Methods

By rapidly reviewing and analyzing numerous sources and inputs (see Appendix), the COVID-19 State of Vaccine Confidence 

Insights Report emphasizes major themes influencing COVID-19 vaccine hesitancy and uptake. These are characterized by the 

level and type of threat to vaccine confidence, degree of spread, and directionality. In addition, by examining how consumers 

think and feel, the social processes, and the practical issues around vaccination, the Insights Report seeks to identify emerging 

issues of misinformation, disinformation, and places where intervention efforts can improve vaccine confidence across the 

United States. 

The information in this report is only a snapshot, and certain populations may be underrepresented. Images and quotes are 

illustrative examples and are not meant to comprehensively cover all content related to the highlighted themes.  

How do you classify this theme/information? 

High risk Moderate risk Low risk Positive sentiment

 May lead to vaccine 

refusals and decreased 

uptake 

 Wide reach, pervasive  

 Potential to trigger 

hesitancy to vaccination

 Moderate reach, modest 

dissemination 

 Concerning, but low risk 

to vaccine confidence 

 Limited reach, limited 

dissemination 

 Could increase vaccine 

confidence, intent, or 

motivation

 Variable reach and 

dissemination

How has this theme/idea changed over time (since last report or over the course of multiple reports)? 

Increasing

Information spreading rapidly 

Stable

Information remaining 

constant at prior level 

Decreasing

Information is not gaining further 

traction and there has been no 

indication of additional activity 
Page: 3

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Major Theme Impacting Vaccine Confidencea,b

Consumers continue to express their concerns about actual and potential COVID-19 

vaccine side effects.

Although some side effects from COVID-19 vaccines are normal and expected,1 concern about adverse events and long-term 

effects from the vaccine keep many from seeking COVID-19 vaccination.2,3

  On May 5, 2022, the FDA limited the authorized 

use of the Janssen COVID-19 Vaccine to individuals ages 18 years and older for whom other authorized or approved COVID-19 

vaccines are not accessible or clinically appropriate, and to individuals ages 18 years and older who elect to receive the Janssen 

COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine.4

 This decision spurred online conversations 

discussing the perceived lack of effectiveness of all COVID-19 vaccines, further discouraging vaccine uptake.5,6,7

Perceptions, Concerns, and Threats to Vaccine Confidence 

 Hepatitis. Some consumers are concerned that rising hepatitis cases in 

children are caused by COVID-19 vaccines.8,9,10 Although CDC includes 

COVID-19 vaccination in its potential cause hypothesis, COVID-19 vaccines 

have been ruled out because many children were too young to be eligible 

for vaccination at the time of rising cases.11,12

 Myocarditis. Although COVID-19 vaccine-related myocarditis is much 

lower for children than teens,13 personal anecdotes14 and reports of 

hospitalization15 following myocarditis continue to negatively impact 

vaccine confidence.16,17,18 CDC and its partners are actively monitoring 

reports of myocarditis and pericarditis after COVID-19 vaccination and CDC 

gives regular public updates about the risks of myocarditis and pericarditis 

after mRNA vaccination, predominantly in adolescents and young adult 

males within several days after COVID-19 vaccination.19

 One CDC study found that “the incidence of cardiac outcomes after 

mRNA COVID-19 vaccination was highest for males aged 12–17 years after the second vaccine dose; however, within this 

demographic group, the risk for cardiac outcomes was 1.8–5.6 times as high after SARS-CoV-2 infection than after the second 

vaccine dose.”20 Another study “found that the risk for cardiac complications was significantly higher after SARS-CoV-2 

infection than after mRNA COVID-19 vaccination for both males and females in all age groups.”21

 Vaccine-acquired Immune Deficiency Syndrome and HIV. Online rumors continue to spread stating that COVID-19 

vaccines cause vaccine-acquired immune deficiency syndrome (VAIDS) and HIV.22,23,24 The State of Vaccine Confidence Report 

#24 detailed the evolution of the VAIDS narrative to concerns about HIV. Social media users are further bolstering this false 

claim, using it as a rationale to resist vaccination.25,26 However, there is no association between COVID-19 vaccines and risk for 

HIV infection.27

 Impaired Immunity. Some social media users are sharing a pre-print manuscript of a study that has not been peer-reviewed28

claiming that mRNA vaccines harm long-term immunity.29,30 Due to this and other safety concerns, some social media users 

are claiming vaccines do more harm than infection-induced immunity.31,32 CDC maintains COVID-19 vaccination causes a more 

predictable immune response than infection with the virus that causes COVID-19. Getting a COVID-19 vaccine gives most 

people a high level of protection against COVID-19-related complications, hospitalizations, and deaths.33

Fertility, reproductive health, and lactation. Some consumers are 

hesitant to get the COVID-19 vaccine due to fear of long-term effects 

on fertility,34,35 lactation,36 and pregnancy.37,38 Additionally, social media 

users are concerned about the effects vaccine can have on fetuses.39,40,41

Many studies have shown that COVID-19 vaccines are safe for people 

who would like to have a baby and carry no long-term effects on 

female reproductive systems.42,43,44

a

Citations in this report are illustrative examples and are not the total number of instances of the corresponding themes

b

Social media posts referenced throughout this report can be found in this online document.
Page: 4

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Identified misinformation themes that may impact vaccine confidencec

 Some consumers believe that the COVID-19 side effects listed in released Pfizer documents45 prove Pfizer lied about the 

number of Pfizer-BioNTech COVID-19 vaccine-related adverse events,46 engaged in fraudulent and dishonest vaccine 

research,47,48 and this vaccine has negative impacts on fertility, pregnancy, and lactation.49,50

Ways public health and partners can take action to improve vaccine confidence 

 Clarify the benefits of COVID-19 vaccines, including boosters, in preventing severe disease. 

 Work with community members and trusted messengers to create and disseminate messages that explain that some side 

effects are normal and expected. If a vaccinated individual gets COVID-19, vaccination will increase the chances that it is a 

mild case. 

 Disseminate messages debunking circulating misinformation when the misinformation persists or it has a high potential to 

impact vaccination uptake in your community. Craft messages that use these evidence-based messaging strategies such as:

 For XYZ to occur, these are the plausible biological mechanisms that would be required, and this is why that is not likely.

 It is not possible for the vaccines to cause XYZ because of this reason.

 We looked into XYZ by reviewing DATA SOURCE A and DATA SOURCE B, and we didn’t find it.

 We know what could cause XYZ and it is CAUSE, not the vaccine.

 There is no evidence that XYZ is true.

 Encourage healthcare workers and public health officials to be transparent about possible vaccine side effects (myocarditis, 

fever, body aches, etc.). Similarly, create communications materials showing the lack of evidence that COVID-19 vaccines are 

associated with AIDS, hepatitis, impaired immunity, and long-term effects on fertility, pregnancy, and lactation. 

c

All social media posts that are used as citations in the identified misinformation sections for this report can be found online through 

this link.
Page: 5

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Continuing and Evolving Themes Impacting Vaccine Confidence

The themes below have been noted in previous reports and continue to undermine vaccine confidence. The information 

highlighted below focuses on what is new or different from previous reports. For additional context and previous 

recommendations on these themes, see previousInsights Reports.

Consumers continue to express their lack of concern about COVID-19 despite rising cases 

and 1 million dead Americans.

CDC’s COVID Data Tracker51 indicates a 

peak of approximately 157,329 daily new 

infections during this reporting period 

on May 31, 2022. Although current 

cases are a fraction of the peak daily 

new infection during the Omicron wave 

(daily cases exceeded 800,000),52 CDC 

COVID-19 Community Levels for more 

than 55% of the population were in a 

‘medium’ or ‘high’ designation.53

Online discussions of current vaccine efficacy against dominant variants may be due to reports of waning COVID-19 vaccineacquired immunity,54,55 breakthrough infection and death,56 and research supporting such claims.57 Despite increasing numbers 

of cases58 and domestic COVID-19-attributed deaths surpassing 1 million individuals,d

 general consumer awareness and 

concern regarding SARS-CoV-2 is at the lowest point since July 2021. Google searches related to the COVID-19 vaccine during 

this reporting period remained low relative to other topics such as Uvalde, TX, and monkeypox.e

 According to a Meltwater 

trends analysis, there was a 17% decrease in news coverage and 45% decrease in social media mentions of COVID-19 vaccines.f

Recent polling indicates fewer than a third of domestic consumers report being “somewhat” or “very” worried about contracting 

COVID-19.59

Additionally, sources indicate vaccine uptake plateauing,g as of May 31, 2022, COVID Data Tracker reported that 77.9% of 

people had received at least one shot60 and 66.7% were fully vaccinated.61 Reported intention to vaccinate maintains a similarly 

consistent cadence since approximately August 2021.c,62,63

The FDA64 and CDC65 strengthened recommendations and expansion of booster eligibility. This did not positively impact 

Google searches, which showed a decreasing interest in booster information, from a recent peak at the end of March 2022.66,67

Perceptions, Concerns, and Threats to Vaccine Confidence 

 Competing national events,68 continued rollback of mitigation measures,69 and consistently decreasing coverage from social 

media, news media, and political sources70,71,72 may lessen the frequency and impact of COVID-19-specific information for 

consumers. 

d

Tanaq Social Listening Report

e

Google Trends

f

Meltwater

g

HHS CET Wave 63
Page: 6

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

 Consumers question the effectiveness of COVID-19 vaccines73 as stories of breakthrough infections persist.74,75 Moreover, 

reports of vaccines’ decreased efficacy against new dominant variants76 and waning vaccine immunity77,78 appear to negatively 

impact consumer confidence in COVID-19 vaccines79 and pharmaceutical brands.80

 Online consumers continue to question whether testing81 and wastewater surveillance methods are effective or accurate.82,83

Commonly asked questions and queries from the publich

 With reports of high rates of cases and previous infection,84,85 is it still necessary to receive a primary series of a COVID-19 

vaccine or a booster dose?

 COVID-19 vaccines are effective at protecting you from severe outcomes and death from the virus that causes COVID-19, 

even if you have had COVID-19 in the past.86 Vaccination is an important tool to help us get back to normal.87

 Should masks still be worn in indoor public places?88

 When making decisions about community-level and individual-level prevention strategies, health officials, stakeholders 

and individuals might consider using the CDC’s COVID-19 Community Levels approaches within their local context. Layered 

prevention strategies, such as staying up to date with vaccines, screening and testing in high-risk settings, improving 

ventilation, and wearing masks, can help limit severe disease and reduce the potential for strain on the healthcare system. 

CDC recommends using county COVID-19 Community Levels to help determine which COVID-19 prevention measures 

to use for individuals and communities. COVID-19 Community Levels do not apply in healthcare settings like hospitals 

and nursing homes. Healthcare settings are recommended to continue to follow CDC’s infection prevention and control 

recommendations for healthcare workers.89

 Should masks90,91 and vaccines92,93 still be utilized as personal mitigation measures when traveling? 

 COVID-19 vaccines help your body develop protection from the virus that causes COVID-19. Although vaccinated people 

sometimes get infected with the virus that causes COVID-19, staying up to date on COVID-19 vaccines significantly lowers 

the risk of getting very sick, being hospitalized, or dying from COVID-19. CDC recommends that everyone who is eligible get 

a booster and stay up to date on their COVID-19 vaccines, especially people with weakened immune systems.

94

 Layered prevention strategies — like staying up to date with vaccines and wearing masks — can help prevent COVID-19 and 

reduce the potential for strain on the healthcare system. Wear a mask with the best fit, protection, and comfort for you.95

 Mask use recommendations are available here.

Identified misinformation themes that may impact vaccine confidence 

 Some consumers believe that natural immunity is superior to vaccine-induced immunity despite the health risks associated 

with getting SARS-CoV-2.96

 Some social media users state that the efficacy of the Pfizer vaccine is only between 1 and 12 percent at preventing illness97

while leaving out the additional context that the vaccine-acquired immunity decreases with time, the vaccines are less 

effective against some variants of SARS-CoV-2, and, most importantly, the vaccine provides protection against severe illness.98

 Some social media users believe SARS-CoV-2 is the same as influenza.99

 Some social media users believe COVID-19 vaccines are causing a surge in the number of COVID-19 cases.100

Ways public health and partners can take action to improve vaccine confidence 

 Develop and amplify messages explaining why vaccines are still important in the COVID-19 prevention response.

 Disseminate messages about community-level risk and corresponding COVID-19 mitigation measures.

 Continue to encourage vaccinations and staying up to date with vaccine boosters by suggesting employers offer time off to 

get vaccines and recover from side effects.

 Monitor and update the public on the COVID-19 vaccines’ effectiveness against variants and communicate any concerns in 

real time.  

 Create messages that encourage people who are vaccinated to support their friends and family to get the COVID-19 vaccines. 

h

These questions come from online data sources such as social media, news stories, Google Trends, and CDC-INFO
Page: 7

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Parents continue to express concern and hesitation regarding COVID-19 vaccination in 

children. 

As of June 18, 2022, everyone 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19 vaccine. 

On May 17, 2022, the FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine, authorizing 

a single booster dose for children ages 5-11 years at least five months after completion of a primary series with the same 

vaccine.101 The FDA committee that reviews and evaluates data concerning the safety, effectiveness, and appropriate use of 

vaccines, VRBPAC (Vaccines and Related Biological Products Advisory Committee), meet on June 14–15, 2022 to discuss the 

emergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022, the Advisory Committee on Immunization 

Practices (ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5 

years and the Pfizer COVID-19 vaccine 

for use in children ages 6 months to 4 

years.103 Some parents have expressed 

enthusiasm and relief about childhood 

vaccination.104,105,106 However, a recent 

Kaiser Family Foundation (KFF) poll 

found that only 18% of parents with 

children younger than 5 years will get 

their child vaccinated right away, while 

38% say they plan to wait and see how 

the vaccine is working for others, 27% 

say they will definitely not get their child 

vaccinated, and 11% say they will only do 

so if they are required.107,108

Perceptions, Concerns, and Threats to Vaccine Confidence 

 Concerns about side effects, such as myocarditis, may negatively impact vaccine uptake.109,110

 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group.111,112

 Some believe infection-induced immunity protects children better than vaccines.113,114

 Some social media users do not think there is enough data to support vaccination against COVID-19 in children.115,116,117

 With cases of hepatitis in children rising globally, some believe they are caused by COVID-19 vaccines.118,119,120

 Some are concerned that immunity from vaccines decreases rapidly in adolescents.122,123

Commonly asked questions and queries from the public  

 Should children under the age of 5 years still wear masks?i

 Wearing a well-fitting mask or respirator consistently and correctly reduces the risk of spreading the virus that causes 

COVID-19. At a high COVID-19 Community Level, universal indoor masking in schools and ECE programs is recommended, 

as it is in the community at-large. Schools with students at risk for getting very sick with COVID-19 must make reasonable 

modifications or accommodations when necessary to ensure that all students, including those with disabilities, are able 

to access in-person learning. Because mask use is not recommended for children ages younger than 2 years and may be 

difficult for very young children or for some children with disabilities who cannot safely wear a mask, ECE programs and 

K-12 schools may need to consider other prevention strategies—such as improving ventilation and avoiding crowding—

when the COVID-19 Community Level is medium or high or in response to an outbreak. K-12 schools or ECE programs may 

choose to implement universal indoor mask use to meet the needs of the families they serve, which could include people at 

risk for getting very sick with COVID-19.124

 Is the COVID-19 vaccine the cause of recent hepatitis cases in children?d

 There is no evidence that COVID-19 vaccine causes hepatitis.125 CDC continues to examine possible causes, including testing 

for and ruling out some of the viruses that commonly cause hepatitis (hepatitis A, B, C, D, and E). Adenovirus has been 

detected in nearly half of the children and continues to be investigated as a candidate for the underlying cause. Further 

laboratory tests are being conducted to look more closely at the virus genome and other potential pathogens, such as 

i

CDC-INFO
Page: 8

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

SARS-CoV-2. In addition, CDC is communicating with key medical groups and continues to provide updated reporting and 

laboratory guidance for clinicians who may identify hepatitis of unknown cause in children.126

 When will vaccines be available for children ages 5 years and younger?d

 As of June 18, 2022, everyone ages 6 months and older is recommended to get a Moderna or Pfizer-BioNTech COVID-19 

vaccine.

127

 Identified misinformation themes that may impact vaccine confidence

 Some social media users believe authorizing vaccines in children is only a ploy for pharmaceutical companies to make 

money.128

 Some social media users claim that COVID-19 cases in children are always mild.129,130,131   w

Ways public health and partners can take action to improve vaccine confidence 

 Encourage primary care providers and other medical professionals who care for children to explain the benefits of COVID-19 

vaccination to parents and guardians. 

 Develop communications materials detailing the benefits of vaccination compared to infection-induced immunity.  

 Clarify the absence of an association between hepatitis and COVID-19 vaccines. 
Page: 9

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Emerging Misinformation Theme Affecting Vaccine Confidence 

Consumers have questions about the relationship between COVID-19 vaccines and 

monkeypox.

On May 18, 2022, a U.S. resident tested positive for monkeypox after returning to the United States from Canada.132 As of 

September 14, 2022, the CDC reports 24,846 confirmed cases of monkeypox with cases in every state.133  Monkeypox virus is a 

completely different virus than the viruses that cause COVID-19 or measles.134  

Perceptions, Concerns, and Threats to Vaccine Confidence 

 Some consumers believe there is a link between COVID-19 vaccines and monkeypox.

135,136

Commonly asked questions and queries from the public 

 Who is at risk for monkeypox?d

 Data suggest that gay, bisexual, and other men who have sex with men make up the majority of cases in the 2022 

monkeypox outbreak. However, monkeypox can spread to anyone through close, personal, often skin-to-skin contact. 

Anyone who has been in close contact with someone who has monkeypox is at risk.137

 How do I know if I have monkeypox?d

 People with monkeypox can get a rash that may be located on or near the genitals (penis, testicles, labia, and vagina) or 

anus (butthole) and could be on other areas like the hands, feet, chest, face, or mouth. 

 The rash will go through several stages, including scabs, before healing.

 The rash can initially look like pimples or blisters and may be painful or itchy.

 Other symptoms of monkeypox can include:

 Fever

 Chills

 Swollen lymph nodes

 Exhaustion

 Muscle aches and backache

 Headache

 Respiratory symptoms (e.g., sore throat, nasal congestion, or cough)

 You may experience all or only a few symptoms

 Sometimes people have flu-like symptoms before the rash.

 Some people get a rash first, followed by other symptoms.

 Others only experience a rash.138

 Are there any travel restrictions due to monkeypox? d

 Recommendation for travelers:139

 If you have monkeypox symptoms or had close contact with someone who 

has monkeypox, talk to your healthcare provider. If you have symptoms, do not 

travel until you confirm that you do not have monkeypox.

 If you have monkeypox and must travel:

» Make sure that you do not have fever or respiratory symptoms such as sore 

throat, nasal congestion, or cough.

» Cover your rash and wear a well-fitting mask.

» Take additional steps to prevent spread to others.

 Visit https://www.cdc.gov/poxvirus/monkeypox/travel/index.html for the most up to date information.

 Is there a monkeypox vaccine? If so, will everyone need it? 

 Two vaccines may be used for the prevention of monkeypox disease:

 JYNNEOS vaccine is approved for the prevention of monkeypox disease.

 ACAM2000 vaccine was made available for use against monkeypox under an Expanded Access Investigational New Drug 

(EA-IND) protocol.140

 CDC recommends that the monkeypox vaccine be given within 4 days from the date of exposure in order to prevent onset 

of the disease. If given between 4–14 days after the date of exposure, vaccination may reduce the symptoms of disease, but 

may not prevent the disease.141
Page: 10

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox such as:142

 Gay, bisexual, and other men who have sex with men, transgender or nonbinary people who in the past 6 months have 

had

» A new diagnosis of one or more nationally reportable sexually transmitted diseases (i.e., acute HIV, chancroid, 

chlamydia, gonorrhea, or syphilis)

» More than one sex partner

 People who have had any of the following in the past 6 months:

» Sex at a commercial sex venue

» Sex in association with a large public event in a geographic area where monkeypox transmission is occurring

 Sexual partners of people with the above risks

 People who anticipate experiencing the above risks

 Identified misinformation themes that may impact vaccine confidence

 Some social media users believe COVID-19 vaccines weaken the body’s immune system, making vaccinated individuals more 

susceptible to monkeypox.143,144

 Some social media users believe monkeypox is caused by COVID-19 vaccines.145,146

 Some social media users believe monkeypox is being used to scare people now that COVID-19 is not seen as a threat.147,148

 Some social media users believe pharmaceutical companies are attempting to create a monkeypox pandemic to increase 

company profits.149,150

Ways public health and partners can take action to improve vaccine confidence 

 Encourage local health departments, public health experts, and healthcare workers to explain the absence of association 

between COVID-19 vaccines and monkeypox. 

 Utilize proper risk communication strategies when communicating about monkeypox, including creating tailored, effective 

communication with trusted messengers that explain both what is known and what is not known about the spread and 

outcomes of monkeypox infection.151

 Create and disseminate graphics through trusted messengers that show the difference in the structure of the virus particles 

and virions for the virus that causes monkeypox and the virus that causes COVID-19. 
Page: 11

COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022

Appendix: Inputs and Sources

Type Input Cadence Sources Tactics for Utilization

Social Media 

Listening 

& Media 

Monitoring

Communication 

Surveillance Report

Daily on 

weekdays

Google news

 Meltwater

CrowdTangle

Native platform searches

 Share of voice topic analysis to identify 

themes

 Emerging topics 

Meltwater Daily  Facebook, Twitter, Instagram

 Blogs

News media

Online forums

 Share of voice topic analysis

 Emerging theme topics

Identify high reach/velocity topics

OADC (Office of the 

Associate Director of 

Communication) Channel 

COVID-19 Post metrics

Weekly  Sprout Social

Native OADC account analytics

Analyze # of posts, topics 

 Success of messages, # of impressions, 

reach, # engagements

OADC Channel Comment 

Analysis

Daily on 

weekdays

Native platform searches  Sentiment analysis

Identify message gaps/voids

Direct Reports

CDC-INFO Metrics Weekly CDC-INFO inquiry line list

 Prepared response (PR) usage report

Cross-compare PR usage with inquiry 

theme analysis

 Sentiment analysis

Identify information gaps/voids

VTF Media Requests Weekly  Media request line list  Leading indicator for news coverage

Identify information gaps/voids

Web Metrics Weekly  Top pages

Google search queries

 Top FAQs

 Referring domains

Identify information gaps/voids,

Identify keywords/search terms, changes in 

web traffic

Research

Poll Review Weekly Harris Poll, PEW research, Gallup Poll, 

KFF 

New data related to vaccine 

hesitancy

Identify socio-behavior indicators related 

to motivation and intention to vaccinate 

Literature Review Weekly  PubMed, LitCovid, ProQuest Central, 

Altmetric 

New data related to vaccine 

hesitancy

Identify current vaccination intention

Identify barriers to vaccination

Third Party 

Reports

Tanaq Social Listening 

+Media Monitoring Report

Weekly  Meltwater

 Sprout Social

 First Draft

Native platform searches

 Trending topics

Demographic and geographic 

conversation monitoring

CrowdTangle content 

insights report

Biweekly  Facebook  Top pages (voices), groups

General trends/sentiment analysis

News analysis through posts

University of Washington 

St. Louis iHeard

Weekly  Proprietary methods  Survey results

 Emerging threats and data deficits

Vaccine narratives

Project VCTR Weekly  Proprietary methods National and regional trends in negative 

attitudes toward vaccination

Conversations around Legislation

Virality Project Weekly  Proprietary methods  Mis- and disinformation trends related to 

COVID-19 vaccine